Inside Innovation

More than 1,000 transplant patients registered for UW Medicine’s second annual Transplant Celebration in Seattle, bringing together transplant recipients, donors and medical staff.  The event

BrainChild Bio, a biotech company launched out of Seattle Children’s, raised $116 million in Series A funding to advance new treatments for pediatric brain tumors. 

Vancouver, Washington-based Absci is aiming to become the “Apple of biotech,” using generative AI to design medicines faster while building a consumer-focused pharmaceutical brand. Founded

Seattle-based HDT Bio is one of five teams selected by the Advanced Research Projects Agency for Health (ARPA-H) to share up to $125 million in

Just – Evotec Biologics has advanced JST-018, an investigational antibody treatment targeting orthopoxviruses, into a first-in-human Phase 1 clinical trial. Developed under a U.S. Department

A nearly $95 million Seattle research effort will use artificial intelligence to design biological molecules that do not exist in nature, with potential applications ranging

Seattle life sciences leaders told the National Security Commission on Emerging Biotechnology that the region has strong scientific innovation but needs greater domestic manufacturing capacity

Seattle-based Benaroya Research Institute (BRI) received 18 research grants totaling more than $16.2 million during the first half of 2026. The funding will support new

Two Seattle-area health and longevity startups are joining forces as Viome Life Sciences acquires Circulate Health in a deal valued between $15 million and $50

Kirkland-based EIT Pharma announced that the FDA has accepted its New Drug Application for Lonafarnib, an investigational oral treatment for chronic hepatitis D. The life-threatening

Biotech startup InduPro, with operations in Seattle and Cambridge, Mass., raised $77 million in Series B funding as it begins a Phase 1 clinical trial